Litigation Details for Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2016)
✉ Email this page to a colleague
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2016)
Docket | ⤷ Try a Trial | Date Filed | 2016-06-07 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 10,029,011; 6,005,020; 6,031,007 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Amgen Inc. v. Hospira, Inc.
Biologic Drugs cited in Amgen Inc. v. Hospira, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-07-08 | 13 | actual [1] - 13:19 27:10, 29:11, 34:9, 18:3, 18:7, 25:19, BPCIA […19, 24:6, 24:10, 29:11 … a bar for patents 24 those patents. And they should have listed the patents on the …one count of patent infringement under 35 U.S.C. § 271(e)(2)(C) and two counts of patent infringement…’s product. Specifically, U.S. Patent No. 5,756,349 (the “’349 Patent”) is directed to cells which are | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |